亚太丝路投资(00767.HK)拟联手赛默飞世尔发展长寿科学业务
格隆汇 3 月 3日丨亚太丝路投资(00767.HK)宣布,于2021年3月3日,公司与赛默飞世尔科技(香港)有限公司("赛默飞世尔")签订关于发展战略合作伙伴关系的备忘录,双方同意建立战略合作伙伴关系,在探索、开发与分析生物标记在长寿医学及健康研究的应用范围内的其他相关领域战略合作,开发技术方法,解决方案和服务产品。
据悉,赛默飞世尔是科学服务领域的世界领导者,赛默飞世尔致力于以优质的产品与服务说明客户加速生命科学领域的研究,解决在分析领域所遇到的问题和挑战,促进医疗诊断发展,提高实验室生产力。赛默飞世尔的企业使命是说明客户使世界更健康、更清洁、更安全,借助于旗下首要五大品牌Thermo Scientific、Applied
Biosystems、Invitrogen、Fisher Scientific、Instrument and Unity Lab Services,将创新技术、便捷采购方案和实验室运营管理的整体解决方案相结合,为客户、股东和员工创造价值,2020年赛默飞世尔年销售额突破250亿美元。
公告称,赛默飞世尔将为公司优先提供该公司最新技术方法、软件和解决方案。这些技术对于公司发展长寿科学业务的至关重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.